Cargando…
Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2
Since immune system and internal environment in vivo are large and complex, the interpretation of the observed immune effect from the perspective of a single immune cell or antibody seems a little feeble. Many studies have shown that specific antibodies against “ former” viruses have a reduced abili...
Autores principales: | Yang, Yalong, Xu, Fenghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622928/ https://www.ncbi.nlm.nih.gov/pubmed/36330519 http://dx.doi.org/10.3389/fimmu.2022.1008285 |
Ejemplares similares
-
Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
por: Ricke, Darrell O.
Publicado: (2021) -
Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE)
por: Peron, Jean Pierre Schatzmann, et al.
Publicado: (2020) -
Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires FcγRIIB and virus-antibody complex with bivalent interaction
por: Wang, Shuang, et al.
Publicado: (2022) -
A novel bispecific antibody dual-targeting approach for enhanced neutralization against fast-evolving SARS-CoV-2 variants
por: Kim, Ji Woong, et al.
Publicado: (2023) -
Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19
por: Karthik, Kumaragurubaran, et al.
Publicado: (2020)